Corrigendum to “Regulating SR Protein Phosphorylation through Regions Outside the Kinase Domain of SRPK1” [J. Mol. Biol. 410/1 (2011) 131–145]

2011 ◽  
Vol 411 (2) ◽  
pp. 511
Author(s):  
Ryan M. Plocinik ◽  
Sheng Li ◽  
Tong Liu ◽  
Kendra L. Hailey ◽  
Jennifer Whitesides ◽  
...  
2012 ◽  
Vol 415 (2) ◽  
pp. 454
Author(s):  
Ryan M. Plocinik ◽  
Sheng Li ◽  
Tong Liu ◽  
Kendra L. Hailey ◽  
Jennifer Whitesides ◽  
...  

Structure ◽  
2009 ◽  
Vol 17 (3) ◽  
pp. 352-362 ◽  
Author(s):  
Alex N. Bullock ◽  
Sanjan Das ◽  
Judit É. Debreczeni ◽  
Peter Rellos ◽  
Oleg Fedorov ◽  
...  

2011 ◽  
Vol 410 (1) ◽  
pp. 131-145 ◽  
Author(s):  
Ryan M. Plocinik ◽  
Sheng Li ◽  
Tong Liu ◽  
Kendra L. Hailey ◽  
Jennifer Whitehouse ◽  
...  

FEBS Journal ◽  
2017 ◽  
Vol 284 (15) ◽  
pp. 2482-2500 ◽  
Author(s):  
Sotiria Drakouli ◽  
Aggeliki Lyberopoulou ◽  
Maria Papathanassiou ◽  
Ilias Mylonis ◽  
Eleni Georgatsou

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Ursula Rauch ◽  
Andreas Eisenreich ◽  
Wolfgang Poller ◽  
Heinz-Peter Schultheiss

Background: Higher eukaryotes control gene expression and increase protein diversity by alternative splicing of pre-mRNA. The Cdc2-like kinase (Clk) family, DNA topoisomerase I (DNA topo I) or Akt kinase are involved in splicing control by regulating the phosphorylation state of serine/arginine rich (SR) proteins. We recently showed that alternatively spliced human tissue factor (asHTF), a soluble isoform of tissue factor (TF), the primary initiator of coagulation, is expressed in HUVECs in response to inflammatory cytokines. This study investigated the role of Clks, DNA topo I and the PI3K-Pathway in regulation of TF-splicing in TNF-α induced HUVECs. Methods: HUVECs were incubated with inhibitors of Clks, DNA-topo I or PI3K and were then stimulated with TNF-α. The SR protein phosphorylation state was determined 2 min post induction. The full length (fl) TF and asHTF mRNA were assessed 60 min post induction by Real-Time PCR. Proteins were measured 5 and 8 hours after stimulation by Western blots and the cell thrombogenicity was analyzed via a chromogenic assay. Results: TNF-α inceased the mRNA expression of asHTF and flTF in HUVECs. The Clk-inhibitor completely inhibited the TNF-α induced expression of asHTF and reduced flTF by 30 %. Inhibition of DNA topo I increased asHTF expression and reduced the flTF expression. Inhibition of the PI3K/Akt-pathway had no effect on TF mRNA expression. Reduced Clk-inhibition the TF activity by 50 % whereas DNA topo I inhibition significantly decreased the procoagulant TF activity 8 hours post TNF-α induction. The Clk- and DNA-topo I-inhibitors altered the SR-protein phosphorylation pattern post TNF-α-induction. Additionally resulted inhibition of Clks in the generation of a third TF mRNA-splice variant, TF-A. Conclusion: Selective inhibition of Clks or DNA topo I leads to alterations of SR-protein phosphorylation and affects the differential expression of TF isoforms, thereby modulating the thrombogenicity of HUVECs. The inhibition of Clks contributes to the generation of a third TF splice variant. The inhibition of these kinases gives new insights into the regulation of the TF gene splicing process, which may result in new therapeutic strategies for modulating cellular thrombogenicity.


2019 ◽  
Vol 39 (3) ◽  
Author(s):  
Kensuke Ninomiya ◽  
Shungo Adachi ◽  
Tohru Natsume ◽  
Junichi Iwakiri ◽  
Goro Terai ◽  
...  

2002 ◽  
Vol 368 (2) ◽  
pp. 527-534 ◽  
Author(s):  
Zhaohua TANG ◽  
Norbert F. KÄUFER ◽  
Ren-Jang LIN

The unexpected low number of genes in the human genome has triggered increasing attention to alternative pre-mRNA splicing, and serine/arginine-rich (SR) proteins have been correlated with the complex alternative splicing that is a characteristic of metazoans. SR proteins interact with RNA and splicing protein factors, and they also undergo reversible phosphorylation, thereby regulating constitutive and alternative splicing in mammals and Drosophila. However, it is not clear whether the features of SR proteins and alternative splicing are present in simple and genetically tractable organisms, such as yeasts. In the present study, we show that the SR-like proteins Srp1 and Srp2, found in the fission yeast Schizosaccharomyces pombe, interact with each other and the interaction is modulated by protein phosphorylation. By using Srp1 as bait in a yeast two-hybrid analysis, we specifically isolated Srp2 from a random screen. This Srp interaction was confirmed by a glutathione-S-transferase pull-down assay. We also found that the Srp1—Srp2 complex was phosphorylated at a reduced efficiency by a fission yeast SR-specific kinase, Dis1-suppression kinase (Dsk1). Conversely, Dsk1-mediated phosphorylation inhibited the formation of the Srp complex. These findings offer the first example in fission yeast for interactions between SR-related proteins and the modulation of the interactions by specific protein phosphorylation, suggesting that a mammalian-like SR protein function may exist in fission yeast.


Endocrinology ◽  
2008 ◽  
Vol 150 (5) ◽  
pp. 2087-2097 ◽  
Author(s):  
Kun Jiang ◽  
Niketa A. Patel ◽  
James E. Watson ◽  
Hercules Apostolatos ◽  
Eden Kleiman ◽  
...  

Serine/arginine-rich (SR) proteins play essential roles in the constitutive and regulated splicing of precursor mRNAs. Phosphorylation of the arginine/serine dipeptide-rich (RS) domain by SR protein kinases such as Cdc2-like kinases (Clk/Sty) modulates their subcellular localization and activation. However, it remains unclear how these kinases and their target SR proteins are regulated by extracellular signals. Regulation of protein kinase C βII (PKCβII) pre-mRNA alternative splicing via exon inclusion by Akt2, a central kinase in insulin action, involves phosphorylation of SR proteins. Here we showed that Akt2, in response to insulin, resulted in phosphorylation of Clk/Sty, which then altered SR protein phosphorylation in concert with Akt2. Insulin-stimulated PKCβII pre-mRNA splicing was blocked by Clk/Sty and phosphatidylinositol-3-kinase inhibitors, and diabetic Akt2-null mouse tissues had impaired phospho-Clk/Sty, SR protein phosphorylation, and PKCβII expression. Furthermore, we observed that Akt2 phosphorylated several SR proteins distinct from Clk/Sty in response to insulin. Akt2-catalyzed phosphorylation of Clk/Sty and SR proteins revealed a role for both kinases in splicing regulation indicating dual functions for Akt2 in response to insulin in this pathway.


Sign in / Sign up

Export Citation Format

Share Document